Nicotine free cigarettes is one of 239 small molecule programs targeting Cardiovascular Disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
686 competitors in Lung Cancer
Nicotine free cigarettes
Tecentriq
Libtayo
Vizimpro
Talzenna
Folvite
Xylocaine
Immunotherapy
Paclitaxel and Carboplatin
Rilotumumab
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources